Fri, Dec 19, 2014, 10:58 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Apricus Biosciences, Inc. Message Board

  • mecosmo2 mecosmo2 Jan 13, 2014 10:00 AM Flag

    Richard Pascoe, CEO of Apricus Biosciences, Company, Added to KemPharm's Board

    CORALVILLE, Iowa, Jan. 13, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today the appointment of Richard Pascoe, CEO of Apricus Biosciences, and Joseph B. Saluri, Vice-President - General Counsel, Stine Seed Company, to the company's Board of Directors. The additions of Mr. Pascoe and Mr. Saluri bring extensive public company and business development experience to KemPharm as the company prepares for multiple clinical and business milestones in 2014, including the expected submission of a New Drug Application (NDA) for KP201, KemPharm's lead clinical candidate, in the third quarter of 2014.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • its not like the guy makes presenntaion after presentation and has done al he can for us and the big $$ we pay him---.. now on his resume he was a huge success at Somx-- how people want you to believe what they want you to believe....

      Sentiment: Hold

 
APRI
0.95-0.0480(-4.81%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.